Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 5.94
+0.10 (1.71%)
Sep 29, 2025, 9:49 AM CET
Hyloris Pharmaceuticals Revenue
Hyloris Pharmaceuticals had revenue of 3.34M EUR in the half year ending June 30, 2025, with 74.54% growth. This brings the company's revenue in the last twelve months to 8.46M, up 30.42% year-over-year. In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M with 159.64% growth.
Revenue (ttm)
8.46M
Revenue Growth
+30.42%
P/S Ratio
19.33
Revenue / Employee
172.63K
Employees
49
Market Cap
163.52M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.66B |
| UCB SA | 6.85B |
| Financière de Tubize | 13.26K |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| Onward Medical | 2.72M |
| Nyxoah | 4.93M |
| Sequana Medical NV | 105.50K |